Anzeige
Mehr »
Donnerstag, 24.07.2025 - Börsentäglich über 12.000 News
Neubewertung voraus? Wird die Aktivierung der EU-Lizenz zum Kurs-Katalysator für die Neubewertung?
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
PR Newswire
201 Leser
Artikel bewerten:
(1)

Blood Pressure Cuffs Market worth $1.3 billion in 2032 with 9.0% CAGR | MarketsandMarkets

DELRAY BEACH, Fla., July 23, 2025 /PRNewswire/ -- The global Blood Pressure Cuffs Market, valued at US$0.6 billion in 2024 stood at US$0.7 billion in 2025 and is projected to advance at a resilient CAGR of 9.0% from 2025 to 2032, culminating in a forecasted valuation of US$1.3 billion by the end of the period. The increasing global burden of chronic non-communicable diseases, including hypertension, obesity, and cardiovascular disorders, primarily drives the expansion of the blood pressure monitoring market. These conditions significantly increase blood pressure levels, necessitating consistent monitoring and management. Moreover, heightened public and clinical awareness of hypertension and its associated complications has led to greater demand for effective diagnostic and monitoring solutions. Concurrently, market growth is further supported by continuous technological advancements and product innovation by key industry players. These developments include introducing non-invasive, automated, and wearable blood pressure monitoring devices to improve accuracy, usability, and patient compliance.

MarketsandMarkets Logo

Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=14931460

Browse in-depth TOC on "Blood Pressure Cuffs Market"

376 - Tables

50 - Figures

309 - Pages

By type, the blood pressure cuffs market is divided into automated and manual segments. Appropriately validated automated blood pressure measuring devices (BPMDs) are considered the preferred standard for clinical diagnosis and management of hypertension. The growth of the automated segment is primarily fueled by the increasing incidence of cardiovascular diseases and the widespread adoption of advanced technologies that offer greater accuracy, ease of use, and efficiency in blood pressure monitoring.

By end users, the blood pressure cuffs market is segmented into hospitals, home care settings, ambulatory care centers, urgent care centers, primary centers, and other end users. As of 2024, the hospitals segment accounted for the largest market share. The large share of the segment can be attributed to the higher purchasing power of hospitals. Hospitals are equipped with advanced monitoring technologies and follow standardized clinical procedures, which ensure reliable blood pressure readings. The growing prevalence of cardiovascular diseases and the increasing number of hospital admissions, especially among the elderly population, further drive demand for high-quality blood pressure cuffs in these settings.

By geography, the blood pressure cuffs market is segmented into five regional segments: North America, Europe, the Asia Pacific, Latin America, and the Middle East & Africa. The Asia Pacific region is expected to grow at the highest CAGR of 10.8% during the forecast period. This rapid expansion is driven by several key factors, including emerging economies such as China, India, and Japan, which are experiencing a surge in healthcare demand. The rising incidence of chronic illnesses, particularly hypertension, and cardiovascular diseases, combined with a growing awareness of early diagnosis and disease prevention, is fueling market growth in the region.

Request Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=14931460

The prominent players in the blood pressure cuffs market include OMRON Corporation, Inc. (Japan), Baxter International, Inc. (US), Koninklijke Philips N.V. (Netherlands), GE HealthCare Technologies, Inc. (US), and McKesson Corporation. (US), B Braun Melsungen AG (Germany), Halma plc (Uk), OSI Systems, Inc. (US), American Diagnostic Corporation (US), Medline Industries, LP. (US), Microlife Corporation (Switzerland), BIOS Medical (UK), ACCOSON (UK), CellBios (India), and Midmark Corporation (US), among others.

BAXTER INTERNATIONAL INC. (US):

Baxter International Inc., through its subsidiaries, provides a broad range of essential healthcare products, including diagnostic & patient monitoring technologies and respiratory care devices. These products are used in diverse healthcare environments such as hospitals, nursing homes, rehabilitation centers, ambulatory surgical centers, physicians' offices, and home care settings under medical supervision. The company operates globally through four main segments: Medical Products and Therapies, Healthcare Systems and Technologies, Pharmaceuticals, and Kidney Care. The Healthcare Systems and Technologies segment-connected care solutions, collaboration platforms, monitoring systems, and diagnostic tools such as blood pressure cuffs-is a key component of Baxter's overall strategy.

OMRON CORPORATION (JAPAN)

OMRON Corporation is a global leader known for offering a diverse portfolio of products across multiple industries. The company operates through four primary business segments: Industrial Automation, Healthcare Business, Social Systems, Solutions and Service Business, and Device & Module Solutions Business. OMRON Healthcare Co., Ltd., a subsidiary of Omron Corporation, specializes in medical devices and health management solutions. This division is recognized as a market leader in cardiovascular care, respiratory health, pain management, remote patient monitoring, and home healthcare equipment-particularly blood pressure monitors.

MCKESSON CORPORATION (US)

McKesson Corporation and its subsidiaries are a prominent provider of diverse healthcare services dedicated to improving patient health outcomes worldwide. The company operates through four main business segments: US Pharmaceutical, Prescription Technology Solutions (RxTS), Medical-Surgical Solutions, and International. The Medical-Surgical Solutions segment plays a key role in delivering a wide range of medical-surgical products-including blood pressure cuffs-as well as logistics, distribution, and support services to various healthcare providers such as physician offices, surgical centers, nursing homes, hospital labs, and home health care agencies. McKesson collaborates with manufacturers and channel partners to effectively serve these markets, focusing on key sectors such as primary care, extended care, government, and other healthcare markets.

For more information, Inquire Now!

Related Reports:

Pulse Oximeter Market

Patient Monitoring Devices Market

Home Healthcare Market

Respiratory Care Devices Market

Pressure Monitoring Market

Get access to the latest updates on Blood Pressure Cuffs Companies and Blood Pressure Cuffs Market Size

About MarketsandMarkets:

MarketsandMarkets has been recognized as one of America's Best Management Consulting Firms by Forbes, as per their recent report.

MarketsandMarkets is a blue ocean alternative in growth consulting and program management, leveraging a man-machine offering to drive supernormal growth for progressive organizations in the B2B space. With the widest lens on emerging technologies, we are proficient in co-creating supernormal growth for clients across the globe.

Today, 80% of Fortune 2000 companies rely on MarketsandMarkets, and 90 of the top 100 companies in each sector trust us to accelerate their revenue growth. With a global clientele of over 13,000 organizations, we help businesses thrive in a disruptive ecosystem.

The B2B economy is witnessing the emergence of $25 trillion in new revenue streams that are replacing existing ones within this decade. We work with clients on growth programs, helping them monetize this $25 trillion opportunity through our service lines - TAM Expansion, Go-to-Market (GTM) Strategy to Execution, Market Share Gain, Account Enablement, and Thought Leadership Marketing.

Built on the 'GIVE Growth' principle, we collaborate with several Forbes Global 2000 B2B companies to keep them future-ready. Our insights and strategies are powered by industry experts, cutting-edge AI, and our Market Intelligence Cloud, KnowledgeStore, which integrates research and provides ecosystem-wide visibility into revenue shifts.

To find out more, visit www.MarketsandMarkets.com or follow us on Twitter , LinkedIn and Facebook .

Contact:
Mr. Rohan Salgarkar
MarketsandMarkets INC.
1615 South Congress Ave.
Suite 103, Delray Beach, FL 33445
USA: +1-888-600-6441
Email: sales@marketsandmarkets.com
Visit Our Website: https://www.marketsandmarkets.com/

Logo: https://mma.prnewswire.com/media/1868219/MarketsandMarkets_Logo.jpg

Cision View original content:https://www.prnewswire.co.uk/news-releases/blood-pressure-cuffs-market-worth-1-3-billion-in-2032-with-9-0-cagr--marketsandmarkets-302511914.html

© 2025 PR Newswire
Hensoldt, Renk & Rheinmetall teuer
Rheinmetall, Renk und Hensoldt haben den Rüstungsboom der letzten Jahre dominiert, doch inzwischen sind diese Titel fundamental heillos überbewertet. KGVs jenseits der 60, KUVs über 4, und das in einem politisch fragilen Umfeld mit wackelnder Haushaltsdisziplin. Für späteinsteigende Anleger kann das teuer werden.

Doch es gibt Alternativen, die bislang unter dem Radar fliegen; solide bewertet, operativ stark und mit Nachholpotenzial.

In unserem kostenlosen Report zeigen wir dir, welche 3 Rüstungsunternehmen noch Potenzial haben und wie du von der zweiten Welle der Zeitenwende profitieren kannst, ohne sich an überhitzten Highflyer zu verbrennen.

Holen Sie sich den neuesten Report! Verpassen Sie nicht, welche Aktien besonders vom weltweiten Aufrüsten profitieren dürften, und laden Sie sich das Gratis-PDF jetzt kostenlos herunter.

Dieses exklusive Angebot gilt aber nur für kurze Zeit! Daher jetzt downloaden!
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.